Swiss companies prepare to take center stage at Bio Europe
A delegation of 26 organizations, including 12 Swiss startups, will exhibit at Bio‑Europe in Cologne, Germany, from 9–11 November. The Swiss startups, many supported by Innosuisse’s GoGlobal initiative, aim to showcase their biotech solutions and secure partnerships and investment opportunities. The event hosts around 6,000 attendees, 3,000 companies, and offers over 30,700 partner meetings.
A delegation of 26 organizations, including 12 Swiss startups, will exhibit at Bio‑Europe in Cologne, Germany, from 9–11 November. The Swiss startups, many supported by Innosuisse’s GoGlobal initiative, aim to showcase their biotech solutions and secure partnerships and investment opportunities. The event hosts around 6,000 attendees, 3,000 companies, and offers over 30,700 partner meetings.
The participation highlights Swiss AI‑driven biotech innovations, such as ALP Bio AG’s organoid‑AI platform, positioning Switzerland as a leader in AI‑enabled drug development.
Original source record. Open the original record to verify the underlying announcement.